¿¸°±¤Àå
ÀÚÀ¯°Ô½ÃÆÇ
Á¦9ȸ ¿À¼Û ±¹Á¦ BIO½ÉÆ÷Áö¾ö |
---|
ÀÛ¼ºÀÚ±è * *µî·ÏÀÏ2010-11-03 |
Future Life with U-Health
¸ð½Ã´Â ±Û
¹ÙÀÌ¿À»ê¾÷ÀÌ Á¤ºÎ°¡ ÃßÁøÇÏ´Â Â÷¼¼´ë ¼ºÀ嵿·Â»ê¾÷À¸·Î ¼±Á¤µÇ¾î ÃßÁøµÇ°í, ¿À¼Û¿¡ ±¹Ã¥±â°ü ¹× ¹ÙÀÌ¿À±â¾÷üÀÇ ÀÔÁÖ°¡ ½ÃÀ۵Ǵ ¡°¿À¼Û»ý¸í°úÇдÜÁö¡±´Â 21¼¼±â µ¿ºÏ¾Æ ¹ÙÀÌ¿À¸ÞÄ«·Î ÀÚ¸® ¸Å±èÇÒ °ÍÀÔ´Ï´Ù. Áö³ÇØ ÃæûºÏµµ ¹Î¡¤°üÀÌ ÈûÀ» ¸ð¾Æ À¯Ä¡ÇÑ ¿À¼ÛÀÇ ¡°Ã·´ÜÀǷẹÇÕ´ÜÁö¡±´Â ¿ÀâÀÇ ¡°¿Àâ°úÇлê¾÷´ÜÁö¡±¿Í ´õºÒ¾î Ȳ±Ý¿¬±¸»ï°¢Ãà (Golden Researh Triangle)À» Çü¼ºÇÏ¿© ÃæºÏÀÇ ¹ßÀü»Ó¸¸ ¾Æ´Ï¶ó ±¹°¡ ¹ßÀü¿¡ ±â¿©ÇÏ°Ô µÉ °ÍÀÔ´Ï´Ù.
ÀÌ·¯ÇÑ ¶æ±íÀº ¶§, ¹Ì·¡ÀÇ »î°ú ±¹°¡ °æÀï·ÂÀ» ÁÖµµÇÒ »ý¸í°úÇÐÀÇ ÀåÀÎ ¡°Future Life with U-Health"¶ó´Â ÁÖÁ¦·Î ±¹³»¿Ü Àú¸íÇÑ ¼®ÇеéÀ» ¸ð½Ã°í Á¦9ȸ ¿À¼Û±¹Á¦¹ÙÀÌ¿À½ÉÆ÷Áö¾öÀ» °³ÃÖÇÏ°Ô µÇ¾ú½À´Ï´Ù.
¹ÙÀÌ¿À»ê¾÷ÀÌ ÃæºÏ ¹ßÀüÀÇ ±âƲÀ» ¸¶·ÃÇÏ°í ³ª¾Æ°¡¼ 21¼¼±â »ý¸í°úÇлê¾÷ÀÇ ºñÁ¯°ú ¹æÇâÀ» Á¦½ÃÇÒ ÀÌ ¶æ±íÀº ÀÚ¸®¿¡ Âü¼®ÇϽþî ÀÚ¸®¸¦ ºû³»Áֽðí ƯÈ÷ BIT À¶ÇÕ »ê¾÷ÀÇ ¹ßÀüÀ» À§ÇÑ °ü½É°ú ¼º¿øÀ» º¸³»Áֽñ⠹ٶø´Ï´Ù.
2010³â 11¿ù
Ãæ û ºÏ µµ Áö »ç ÀÌ ½Ã Á¾
¿À¼Û±¹Á¦BIO½ÉÆ÷Áö¾ö Á¶Á÷À§¿øÀå ±è ÇÐ ¿ë
◉ Çà»ç°³¿ä
- ÀÏ ½Ã : 2010. 11. 05(±Ý) ~ 06(Åä)
- Àå ¼Ò : ÃæºÏ´ëÇб³ °³½Å¹®È°ü ´ë°ø¿¬Àå
- ÁÖ ÃÖ : ÃæûºÏµµ
- ÁÖ °ü : BK21¼¼Æ÷½Ã½ºÅÛÀη¾缺»ç¾÷ÆÀ, ÃæºÏBIT¿¬±¸Á߽ɴëÇÐÀ°¼º»ç¾÷´Ü,
Çѱ¹ÀüÀÚÅë½Å¿¬±¸¿ø, PT-ERC
- ÈÄ ¿ø : º¸°Çº¹ÁöºÎ, ±³À°°úÇбâ¼úºÎ, (Àç)¿À¼Û¹ÙÀÌ¿ÀÁøÈïÀç´Ü, ÃæºÏ´ëÇб³,
Çѱ¹ÀüÀÚÅë½Å¿¬±¸¿ø
Çà»ç¾È³»
<2010³â 11¿ù 05ÀÏ(±Ý)>
10:00~10:15 °³È¸»ç ±èÇпë(¿À¼Û±¹Á¦BIO½ÉÆ÷Áö¾ö Á¶Á÷À§¿øÀå)
ȯ¿µ»ç À̽ÃÁ¾(ÃæûºÏµµÁö»ç)
Ãà »ç ±è½ÂÅÃ(ÃæºÏ´ëÇб³ ÃÑÀå)
±âÁ¶¿¬¼³
10:15~11:15 ECIS (Electrical Cell-Subsrate Impedence Sensing): A New Tool for Tissue Culture
ÁÂÀå : ±è»óÈ¿(°æ¿ø´ëÇб³)
¢º Ivar Giaever(³ëº§»ó ¹°¸®Çкι® ¼ö»ó/Oslo ´ëÇÐ/°æ¿ø´ëÇб³)
Session 1 ¡°U-HealthÀÇ ±âº» °³³ä ÀÌÇØ¡±
ÁÂÀå : ¹Ú¼±Èñ(Çѱ¹¿¬±¸Àç´Ü), Â÷ÀºÁ¾(ÃæºÏ´ëÇб³)
13:30~14:00 State of Practice and Outlook for U-Health Business
¢º ÀüÁø¿Á(ºñÆ®ÄÄÇ»ÅÍ)
14:00~14:30 Supporting Ubiquitous Health through Standards and Interoperatability
¢º Doug Bogia(Intel Corporation)
14:30~15:00 The Law, the Rregulations, and the Healthcare System for Health
Promotion Services - Business Strategy for Emerging Market
¢º ±èÈ«Áø(ÀμºÁ¤º¸ ÀμºÁ¤º¸ U-Health Division)
Session 2 ¡°U-Health °ü·Ã ±â¼ú¡±
ÁÂÀå : ¼º°Ç¿ë(Çѱ¹ÀüÀÚÅë½Å¿¬±¸¿ø), Àå¼öÀÍ(ÃæºÏ´ëÇб³)
15:30~16:00 Recent U-Health Research and Development Trend
¢º ±è½Âȯ(Çѱ¹ÀüÀÚÅë½Å¿¬±¸¿ø)
16:00~16:30 Microfluidic Assay Technologies: From Diagnostics to Personalized
Medicine
¢º ¹ÚÁ¦±Õ(Çѱ¹°úÇбâ¼ú¿ø ³ú ¹× ¹ÙÀÌ¿À ½Ã½ºÅÛ°øÇаú)
16:30~17:00 Single Molecule Raman Spectroscopy
¢º ¼¿µ´ö(Çѱ¹ÈÇבּ¸¿ø À¶ÇÕ¹ÙÀÌ¿À ±â¼ú¼¾ÅÍ)
<2010³â 11¿ù 06ÀÏ(Åä)>
11:00~11:50 ¹Ì·¡°úÇбâ¼ú°ú ¿ì¸®ÀÇ ÀÚ¼¼ ¢º Çѹü´ö(ûÁÖ½Ãû)
13:00~13:50 ±â»ýÃæÀÇ ¿Ã¹Ù¸¥ ÀÌÇØ ¢º ¼ ¹Î(´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ)
14:00~14:30 ½Ã»ó½Ä ¢º Á¦6ȸ BIO»ê¹®Àü, Á¦7ȸ ¹ÙÀÌ¿ÀÇö¹Ì°æ»çÁøÀü
»çÀüµî·Ï¾È³»
À̹ø ±¹Á¦½ÉÆ÷Áö¾öÀÇ µî·Ïºñ´Â ¾ø½À´Ï´Ù. µî·ÏÀ» ¿øÇϽô ºÐÀº 10¿ù 27ÀÏ(¼ö)±îÁö ´ÙÀ½ »çÇ×À» ±âÀçÇÏ¿© e-mail ȤÀº ÀüÈ·Î ¿¬¶ôÁֽñ⠹ٶø´Ï´Ù.
±âÀç»çÇ× : ¼º¸í(±¹¹®, ¿µ¹®) ¼Ò¼Ó(±¹¹®, ¿µ¹®) ÀüȹøÈ£
e-mail.: bio2010@chungbuk.ac.kr / ÀüÈ : 043)261-3649
http://bk21cell.chungbuk.ac.kr
´ëÇ¥¹®ÀÇ
031.828.5841 °øÈÞÀÏ(ÀÏ¿äÀÏ)